Naratuximab Biosimilar - Anti-CD37 Antibody - BSA and Azide free
Description
Recombinant chimeric monoclonal antibody to CD37.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG1
Conjugate
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
HEK293 cell line transfected with irrelevant protein (B) and human CD37 (A) were surface stained with Anti-CD37 Chimeric Antibody [Naratuximab Biosimilar] - Azide free (A318910) at 1 µg/ml followed by Anti-Human IgG Antibody (Alexa 488).
Publishing research using Naratuximab Biosimilar - Anti-CD37 Antibody - BSA and Azide free (A318910)? Please let us know so that we can list the citation on this page.
Alternative products to Naratuximab Biosimilar - Anti-CD37 Antibody - BSA and Azide free (A318910)